AZA-TDC CAPSULES FOR USE IN CLINICAL TRIAL
$177,135N01FY2022CANIH
Irisys, Inc., San Diego CA
Investigators
Abstract
AZA-TDC CAPSULES FOR USE IN CLINICAL TRIAL FOR POSSIBLE CANCER TREATMENT. THE DRUG PRODUCT (DP) WILL BE A 4 MG STRENGTH CAPSULE WHICH IS NOT AVAILABLE
View original record on NIH RePORTER →